Reuters logo
8 months ago
BRIEF-Nivalis Therapeutics announces results from Phase 2 clinical trial of Cavosonstat
November 28, 2016 / 9:25 PM / 8 months ago

BRIEF-Nivalis Therapeutics announces results from Phase 2 clinical trial of Cavosonstat

1 Min Read

Nov 28 (Reuters) - Nivalis Therapeutics Inc

* Nivalis therapeutics announces results from Phase 2 clinical trial of Cavosonstat for treatment of cystic fibrosis

* There were no dose limiting toxicities and cavosonstat was well tolerated at all doses in trial

* Trial failed, however, to demonstrate benefit in absolute change in percent predicted FEV(1), trial's primary endpoint

* Plan to continue to investigate therapeutic potential of cavosonstat and gsnor inhibitor portfolio to determine next steps Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below